Potent inhibitors of pro-inflammatory cytokine production produced by a marine-derived bacterium

Journal of Medicinal Chemistry

Volumn 52, Issue 8, 2009, Pages 2317-2327

  Strangman, Wendy K ^a   Kwon, Hak Cheol ^a   Broide, David ^c   Jensen, Paul R ^a   Fenical, William ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; DEXAMETHASONE; LACTONE DERIVATIVE; SPLENOCIN A; SPLENOCIN B; SPLENOCIN C; SPLENOCIN D; SPLENOCIN E; SPLENOCIN F; SPLENOCIN G; SPLENOCIN H; SPLENOCIN I; SPLENOCIN J; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; EXTRACT; FEMALE; FRACTIONATION; IC 50; MARINE BACTERIUM; MOUSE; NONHUMAN; QUANTITATIVE ASSAY; SPLEEN CELL; STREPTOMYCES; STRUCTURE ANALYSIS; TH2 CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CHEMICAL FRACTIONATION; CYTOKINES; FEMALE; GEOLOGIC SEDIMENTS; LACTONES; MICE; MICE, INBRED BALB C; MOLECULAR CONFORMATION; OCEANS AND SEAS; SPLEEN; STEREOISOMERISM; STREPTOMYCES; TH2 CELLS;

EID: 65249129027     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm801110j     Document Type: Article

References (27)

1. Ikeda, R.; Nayar, J.; Cho, J. Y.; Miller, M.; Rodriguez, M.; Raz, E.; Broide, D. H. Resolution of airway inflammation following ovalbumin challenge. Am. J. Respir. Cell Mol. Biol. 2003, 28, 655-663.
2. Itano, A.; Jenkins, M. Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 2003, 4, 733-739.
3. Greenfeder, S.; Umland, S. P.; Cuss, F. M.; Chapman, R. W.; Egan, R. W. Th2 cytokines and asthma: the role of interleukin-5 in allergic eosinophilic disease. Respir. Res. 2001, 2, 71-79.
4. Wills-Karp, M.; Chiaramonte, M. Interleukin-13 in asthma. Curr. Opin. Pulm. Med. 2003, 9, 21-27.
5. Barnes, P. J. New drugs for asthma. Nat. Rev. Drug Discovery 2004, 3, 831-844.
6. Salvi, S. S.; Krishna, M. T.; Sampson, A. P.; Holgate, S. T. The antiinflammatory effects of leukotriene modifying drugs and their use in asthma. Chest 2001, 119, 1533-1546.
7. Koehn, F.; Carter, G. T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discovery 2005, 4, 206-220.
8. Fenical, W.; Jensen, P. R. Developing a new resource for drug discovery: marine actinomycete bacteria. Nat. Chem. Biol. 2006, 2, 666-673.
9. Barrow, C. J.; Oleynek, J. J.; Marinelli, V.; Sun, H. H.; Kaplita, P.; Sedlock, D. M.; Gillum, A. M.; Chadwisk, C. C; Cooper, R. Antimycins, inhibitors of ATP-citrate lyase, from a Streptomyces sp. J. Antibiotics 1997, 50, 729-733.
10. 16, seven new antimycin antibiotics produced by Streptomyces spp. SPA10191 and SPA-8893. J. Antibiotics 2005, 58, 460-467.
11. Shiomi, K.; Hatae, K.; Hatano, H.; Matsomoto, A.; Takahashi, Y.; Jiang, C.-L.; Tomoda, H.; Kobayashi, S.; Tanaka, H.; Omura, S. A new antibiotic, antimycin A9, produced by Streptomyces sp. K01-0031. J. Antibiotics 2005, 58, 74-78.
12. Fondja Yao, C. B.; Schiebel, M.; Helmke, E.; Anke, H.; Laatsch, H. Prefluostatin and new urauchimycin derivatives produced by Strep-tomycete isolates. Z. Naturforsch. 2006, 61b, 320-325.
13. Ishiyama, T.; Endo, T.; Otake, N.; Yonehara, H. Deisovalerylblast-mycin produced by Streptomyces sp. J. Antibiot. 1976, 29, 804-808.
14. Imamura, N.; Nishijima, M.; Adachi, K.; Sano, H. Novel antimycin antibiotics, urauchimycins A and B, produced by a marine actinomycete. J. Antibiot. 1992, 46, 241-246.
15. Hayashi, K.-I.; Nozaki, H. Kitamycins, new antimycin antibiotics produced by Streptomyces sp. J. Antibiotics 1999, 52, 325-328.
16. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. High-field FT NMR application of mosher's method. The absolute configurations of marine terpenoids. J. Am. Chem. Soc. 1991, 113, 4092-4096.
17. Ohkawa, S.; Fukatsu, K.; Miki, S.; Hashimoto, T.; Sakamoto, J.; Doi, T.; Nagai, Y.; Aono, T. 5-Aminocoumarans: dual inhibitors of lipid peroxidation and dopamine release with protective effects against central nervous system trauma and ischemia. J. Med. Chem. 1997, 40, 559-573.
18. Kikuchi, H.; Saito, Y.; Sekiya, J.; Okano, Y.; Saito, M.; Nakahata, N.; Kubohara, Y.; Oshima, Y. Isolation and synthesis of a new aromatic compound, brefelamide, from dictyostelium cellular slime molds and its inhibitory effect on the proliferation of astrocytoma cells. J. Org. Chem. 2005, 70, 8854-8858.
19. Campbell, T. W.; McCoy, V. E.; Kauer, J. C; Foldi, V. S. Preparation of some 9, 10-difunctional derivatives of 9, 10-dihydro-9, 10-ethanoan-thracene. J. Org. Chem. 1961, 26, 1422-1426.
20. Fujii, K.; Ikai, Y.; Mayumi, T.; Oka, H.; Suzuki, M.; Harada, K. A nonempirical method using LC/MS for determination of the absolute configuration of constituent amino acids in a peptide: elucidation of limitations of Marfey's method and of its separation mechanism. Anal. Chem. 1997, 69, 3346-3352.
21. Fujii, K.; Ikai, Y.; Oka, H.; Suzuki, M.; Harada, K. A nonempirical method using LC/MS for determination of the absolute configuration of constituent amino acids in a peptide: combination of Marfey's method and with mass spectrometry and its practical application. Anal. Chem. 1997, 69, 5146-5151.
22. Berova, N.; Nakanishi, K.; Woody, R. W. Circular Dichroism Principles and Practice, 2nd ed.; Wiley-VCH, Inc.: New York, 2000.
23. Kinoshita, M.; Aburaki, S.; Umezawa, S. Absolute configurations of antimycin lactones and antimycin A. J. Antibiot. 1972, 15, 373-376.
24. Tzung, S.-P.; Kim, K. M.; Basanez, G.; Giedt, C. D.; Simon, J.; Zimmerberg, J.; Zhang, K. Y. J.; Hockenbery, D. M. Antimycin A mimics a cell-death-inducing Bcl-2 homolgy domain 3. Nat. Cell Biol. 2001, 3, 183-191.
25. Maeda, M.; Hasebe, Y.; Egawa, K.; Shibanuma, M.; Nose, K. Inhibition of angiogenesis and HIF-1α activity by antimycin A1. Biol. Pharm Bull. 2006, 29, 1344-1348.
26. Kabir, A. M. N.; Cao, X.; Gorog, D. A.; Bassi, R.; Bellahcene, M.; Quinlan, R. A.; Davis, R. J.; Flavell, R. A.; Shattock, M. J.; Marber, M. S. Antimycin A induced cardioprotection is dependant on pre-ischemic p38 MAPK activation but independant of MKK3. J. Mol. Cell. Cardiol. 2005, 39, 709-717.
27. Broide, D.; Schwarze, J.; Tighe, H.; Gifford, T.; Nguyen, M.-D.; Malek, S.; Van Uden, J. H.; Martin-Orozco, E.; Gelfand, E. W.; Raz, E. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway responsiveness in mice. J. Immunl. 1998, 161, 7054-7062.